Article Text

PDF
Review: corticosteroids plus long-acting β-agonists reduce exacerbations more than long-acting β-agonists alone in COPD

Statistics from Altmetric.com

L J Nannini

Dr L J Nannini, Hospital G. Baigorria, Santa Fe-Rosario, Argentina; nanninilj@cimero.org.ar

REVIEW PROCESS

Question:

in patients with stable chronic obstructive pulmonary disease (COPD), how do inhaled corticosteroids (ICSs) combined with long-acting β-agonists (LABAs) compare with LABAs alone?

Search methods:

Medline, EMBASE/Excerpta Medica, Cochrane Central Register of Controlled Trials, Cochrane Library (Issue 1, 2007), Cochrane Airways Group Specialised Register, 4 other databases, …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.